Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PLD6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CHRNA5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PDS5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHF14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TUG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MARCH6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC643201 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB8A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XPNPEP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LY9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101060835 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HAUS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IKBKAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC400927-CSNK1E - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANAPC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MREG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBC1D14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-DMB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on